menu
    • menu

    Company profile for Obsidian Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Obsidian is a volcanic glass that is used to make sharp and precise blades. Reflecting our namesake, our approach enables precise, patient-specific engineering of cell and gene therapies. Like the diversity of obsidian sources, we value the diversity and unique talents of our people. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partners...
    Obsidian is a volcanic glass that is used to make sharp and precise blades. Reflecting our namesake, our approach enables precise, patient-specific engineering of cell and gene therapies. Like the diversity of obsidian sources, we value the diversity and unique talents of our people. Our aspirations are high, and we’re built to deliver – well-funded with blue chip investors, engaged field-leading advisors, strong partnerships with industry leaders, and a highly experienced, dynamic, innovative and collaborative team, collectively focused on delivering transformative therapies in areas of greatest clinical need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Obsidian TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1030 Massachusetts Ave Cambridge, MA 02138
    Telephone
    Telephone
    (781) 806-6245
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://obsidiantx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/obsidian-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Obsidian_Tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Obsidian Leverages Galera Reverse Merger To Go Public
    Obsidian Leverages Galera Reverse Merger To Go Public

    14 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cell-therapy-biotech-obsidian-leverages-galera-reverse-merger-go-public

    FIERCE BIOTECH
    14 Apr 2026
    Share Share
    Obsidian Therapeutics Names Julie Feder as CFO
    Obsidian Therapeutics Names Julie Feder as CFO

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/obsidian-therapeutics-appoints-julie-feder-as-chief-financial-officer

    PHARMIWEB
    12 Jan 2026
    Share Share
    Obsidian Therapeutics Reports Positive Data on OBX-115 at ASCO
    Obsidian Therapeutics Reports Positive Data on OBX-115 at ASCO

    02 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250602726563/en/Obsidian-Therapeutics-Announces-Positive-Clinical-Data-from-OBX-115-in-Patients-with-Advanced-Melanoma-in-Ongoing-Multicenter-Study-at-the-2025-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting

    BUSINESSWIRE
    02 Jun 2025
    Share Share
    Obsidian Therapeutics to Present Preclinical Data at ASGCT Meeting
    Obsidian Therapeutics to Present Preclinical Data at ASGCT Meeting

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428233100/en/Obsidian-Therapeutics-to-Present-Preclinical-Data-Supporting-Novel-Application-of-cytoDRiVE-Platform-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Obsidian Therapeutics Presents at AACR Annual Meeting
    Obsidian Therapeutics Presents at AACR Annual Meeting

    25 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425392001/en/Obsidian-Therapeutics-Announces-Multiple-Presentations-at-the-American-Association-for-Cancer-Research-Annual-Meeting

    BUSINESSWIRE
    25 Apr 2025
    Share Share
    Obsidian Therapeutics to Present Clinical Data on OBX-115 at 2025
    Obsidian Therapeutics to Present Clinical Data on OBX-115 at 2025

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423449840/en/Obsidian-Therapeutics-to-Present-Clinical-Data-from-OBX-115-its-Engineered-TIL-Cell-Therapy-for-Patients-with-Advanced-Melanoma-in-Oral-Presentation-at-the-2025-ASCO-Annual-Meeting

    BUSINESSWIRE
    23 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search